share_log

Retail Investors Invested in SMO ClinPlus CO.,LTD. (SZSE:301257) Copped the Brunt of Last Week's CN¥379m Market Cap Decline

Retail Investors Invested in SMO ClinPlus CO.,LTD. (SZSE:301257) Copped the Brunt of Last Week's CN¥379m Market Cap Decline

散户投资者投资了 SMO ClinPlus CO.,有限公司(SZSE: 301257) 首当其冲地应对了上周3.79亿人民币市值下跌的冲击
Simply Wall St ·  03/27 18:10

Key Insights

关键见解

  • The considerable ownership by retail investors in SMO ClinPlusLTD indicates that they collectively have a greater say in management and business strategy
  • A total of 6 investors have a majority stake in the company with 51% ownership
  • Insiders own 13% of SMO ClinPlusLTD
  • 散户投资者对SMO ClinplusLtd的大量所有权表明,他们在管理和业务战略中共同拥有更大的发言权。
  • 共有6位投资者持有该公司的多数股权,所有权为51%
  • 内部人士拥有SMO ClinplusLtd13%的股份

To get a sense of who is truly in control of SMO ClinPlus CO.,LTD. (SZSE:301257), it is important to understand the ownership structure of the business. With 28% stake, retail investors possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

了解谁真正控制了 SMO ClinPlus CO., LTD.(深圳证券交易所代码:301257),了解企业的所有权结构很重要。散户投资者拥有公司的最大股份,持有28%的股份。换句话说,该集团将从对公司的投资中获得最多(或损失最大)。

As market cap fell to CN¥2.9b last week, retail investors would have faced the highest losses than any other shareholder groups of the company.

随着上周市值跌至29亿元人民币,散户投资者面临的损失将超过该公司任何其他股东群体。

Let's take a closer look to see what the different types of shareholders can tell us about SMO ClinPlusLTD.

让我们仔细看看不同类型的股东能告诉我们关于SMO ClinplusLtd的信息。

ownership-breakdown
SZSE:301257 Ownership Breakdown March 27th 2024
SZSE: 301257 所有权明细 2024 年 3 月 27 日

What Does The Institutional Ownership Tell Us About SMO ClinPlusLTD?

关于SMO ClinplusLtd,机构所有权告诉我们什么?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

机构投资者通常将自己的回报与常见指数的回报进行比较。因此,他们通常会考虑收购相关基准指数中包含的大型公司。

We can see that SMO ClinPlusLTD does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of SMO ClinPlusLTD, (below). Of course, keep in mind that there are other factors to consider, too.

我们可以看到,SMO ClinplusLtd确实有机构投资者;他们持有该公司很大一部分股票。这意味着在这些机构工作的分析师已经看过这只股票,他们很喜欢。但是就像其他人一样,他们可能错了。如果两个大型机构投资者试图同时抛售股票,股价大幅下跌的情况并不少见。因此,值得查看一下SMO ClinplusLtd过去的收益轨迹(见下文)。当然,请记住,还有其他因素需要考虑。

earnings-and-revenue-growth
SZSE:301257 Earnings and Revenue Growth March 27th 2024
SZSE: 301257 2024年3月27日收益和收入增长

We note that hedge funds don't have a meaningful investment in SMO ClinPlusLTD. Shanghai Xibao Investment Management Co., Ltd. is currently the company's largest shareholder with 19% of shares outstanding. With 8.0% and 7.9% of the shares outstanding respectively, Shihezi Ruixin Equity Investment Partnership Enterprise (Limited Partnership) and Shanghai Guanyou Investment and Development Co., Ltd. are the second and third largest shareholders.

我们注意到,对冲基金没有对SMO ClinplusLtd进行有意义的投资。上海西宝投资管理有限公司目前是该公司的最大股东,已发行股份的19%。石河子瑞信股权投资合伙企业(有限合伙)和上海冠友投资发展有限公司分别占已发行股份的8.0%和7.9%,是第二和第三大股东。

We did some more digging and found that 6 of the top shareholders account for roughly 51% of the register, implying that along with larger shareholders, there are a few smaller shareholders, thereby balancing out each others interests somewhat.

我们做了进一步的挖掘,发现大股东中有6人约占登记册的51%,这意味着除了较大的股东外,还有一些较小的股东,从而在一定程度上平衡了彼此的利益。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. As far as we can tell there isn't analyst coverage of the company, so it is probably flying under the radar.

虽然研究公司的机构所有权可以为您的研究增加价值,但研究分析师的建议以更深入地了解股票的预期表现也是一种好做法。据我们所知,没有分析师对该公司进行报道,因此它可能处于雷达之下。

Insider Ownership Of SMO ClinPlusLTD

SMO ClinplusLtd 的内部所有权

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

公司内部人员的定义可能是主观的,并且在不同的司法管辖区之间确实有所不同。我们的数据反映了个人内部人士,至少涵盖了董事会成员。管理层最终对董事会负责。但是,经理成为执行委员会成员的情况并不少见,尤其是当他们是创始人或首席执行官时。

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

当内部所有权表明领导层像公司的真正所有者一样思考时,内部所有权是积极的。但是,高度的内部所有权也可以赋予公司内部的一小部分人巨大的权力。在某些情况下,这可能是负面的。

Our information suggests that insiders maintain a significant holding in SMO ClinPlus CO.,LTD.. Insiders own CN¥392m worth of shares in the CN¥2.9b company. We would say this shows alignment with shareholders, but it is worth noting that the company is still quite small; some insiders may have founded the business. You can click here to see if those insiders have been buying or selling.

我们的信息表明,内部人士持有SMO ClinPlus CO的大量股份。, LTD.。内部人士拥有这家29亿元人民币公司价值3.92亿元人民币的股份。我们可以说这表明了与股东的一致性,但值得注意的是,该公司仍然很小;一些内部人士可能已经创立了该公司。你可以点击这里查看这些内部人士是否在买入或卖出。

General Public Ownership

一般公有制

With a 28% ownership, the general public, mostly comprising of individual investors, have some degree of sway over SMO ClinPlusLTD. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

SMO ClinplusLtd拥有28%的所有权,主要由个人投资者组成的公众对SMO ClinplusLtd有一定程度的影响力。尽管这个群体不一定能做主,但它肯定会对公司的运作方式产生真正的影响。

Private Equity Ownership

私募股权所有权

With an ownership of 26%, private equity firms are in a position to play a role in shaping corporate strategy with a focus on value creation. Some investors might be encouraged by this, since private equity are sometimes able to encourage strategies that help the market see the value in the company. Alternatively, those holders might be exiting the investment after taking it public.

私募股权公司拥有26%的所有权,可以在制定以价值创造为重点的公司战略方面发挥作用。一些投资者可能会为此感到鼓舞,因为私募股权有时能够鼓励制定有助于市场看到公司价值的策略。或者,这些持有人可能会在投资上市后退出投资。

Private Company Ownership

私人公司所有权

Our data indicates that Private Companies hold 8.0%, of the company's shares. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

我们的数据显示,私人公司持有公司8.0%的股份。可能值得对此进行更深入的研究。如果关联方,例如内部人士,对其中一家私营公司有兴趣,则应在年度报告中予以披露。私营公司也可能在公司中拥有战略利益。

Next Steps:

后续步骤:

While it is well worth considering the different groups that own a company, there are other factors that are even more important.

虽然值得考虑拥有公司的不同群体,但还有其他更为重要的因素。

Many find it useful to take an in depth look at how a company has performed in the past. You can access this detailed graph of past earnings, revenue and cash flow.

许多人发现,深入了解一家公司过去的表现很有用。您可以访问这张过去的收益、收入和现金流的详细图表。

If you would prefer check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, backed by strong financial data.

如果你更愿意去另一家公司看看,一家财务状况可能更好,那么千万不要错过这份由强劲财务数据支持的有趣公司的免费名单。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的数字是使用过去十二个月的数据计算得出的,这些数据是指截至财务报表日期当月最后一天的12个月期间。这可能与全年年度报告数据不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发